This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ghosh, S. ‘Sialic Acid and Biology of Life: An Introduction’, Sialic Acids and Sialoglycoconjugates in the Biology of Life, Health and Disease 2020, pp. 1–61.GhoshS‘Sialic Acid and Biology of Life: An Introduction’Sialic Acids and Sialoglycoconjugates in the Biology of Life, Health and Disease 202016110.1016/B978-0-12-816126-5.00001-9Search in Google Scholar
Varki, A. ‘Biological Roles of Glycans’, Glycobiology, vol. 27, 2017, pp. 3–49.VarkiA‘Biological Roles of Glycans’Glycobiology27201734910.1093/glycob/cww086588443627558841Search in Google Scholar
Li, Y and Chen, X. ‘Sialic Acid Metabolism and Sialyltransferases: Natural Functions and Applications’, Applied Microbiology and Biotechnology; vol. 94, no. 4, 2012, pp. 887–905.LiYChenX‘Sialic Acid Metabolism and Sialyltransferases: Natural Functions and Applications’Applied Microbiology and Biotechnology944201288790510.1007/s00253-012-4040-1353497422526796Search in Google Scholar
Zhou, X, Yang, G, Guan, F. ‘Biological Functions and Analytical Strategies of Sialic Acids in Tumor’, Cells, 9, 2020, p. 273.ZhouXYangGGuanF‘Biological Functions and Analytical Strategies of Sialic Acids in Tumor’Cells9202027310.3390/cells9020273707269931979120Search in Google Scholar
Zhang, Z, Wuhrer, M and Holst, S. ‘Serum Sialylation Changes in Cancer’ Glycoconjugate Journal, vol. 35, 2018, pp. 139–160.ZhangZWuhrerMHolstS‘Serum Sialylation Changes in Cancer’Glycoconjugate Journal35201813916010.1007/s10719-018-9820-0591698529680984Search in Google Scholar
Rodrigues, E and Macauley, MS. ‘Hypersialylation in cancer: Modulation of Inflammation and Therapeutic Opportunities’, Cancers, vol. 10,, no. 6, 2018, p. 207.RodriguesEMacauleyMS‘Hypersialylation in cancer: Modulation of Inflammation and Therapeutic Opportunities’Cancers106201820710.3390/cancers10060207602536129912148Search in Google Scholar
Büll, C, Stoel, MA, Den Brok, MH and Adema, GJ. ‘Sialic Acids Sweeten a Tumor’s Life’, Cancer Res, vol. 74, no. 12, 2014, pp. 3,199–3,204.BüllCStoelMADen BrokMHAdemaGJ‘Sialic Acids Sweeten a Tumor’s Life’Cancer Res741220143,1993,20410.1158/0008-5472.CAN-14-072824830719Search in Google Scholar
Teoh, ST, Ogrodzinski, MP, Ross, C, Hunter, KW, Lunt, SY. ‘Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics’, Front. Oncol, vol. 8, 2018, p 174.TeohSTOgrodzinskiMPRossCHunterKWLuntSY‘Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics’Front. Oncol8201817410.3389/fonc.2018.00174598544929892572Search in Google Scholar
Ugorski, M, Laskowska, A. Sialyl, Lewis a, ‘A Tumor-Associated Carbohydrate Antigen In-Volved in Adhesion and Metastatic Potential of Cancer Cells. Acta Biochemica Plonica’, vol. 49, no 2, 2002 pp. 303–311.UgorskiMLaskowskaASialyl, Lewis a, ‘A Tumor-Associated Carbohydrate Antigen In-Volved in Adhesion and Metastatic Potential of Cancer CellsActa Biochemica Plonica’492200230331110.18388/abp.2002_3788Search in Google Scholar
Seales, EC, Jurado, GA, Singhal, A, Bellis, SL. ‘Ras Oncogene Directs Expression of a Differentially Sialylated, Functionally Altered β1 Integrin’, Oncogene, vol. 22, no. 46, 2003, pp. pp. 7,137–7,145.SealesECJuradoGASinghalABellisSL‘Ras Oncogene Directs Expression of a Differentially Sialylated, Functionally Altered β1 Integrin’Oncogene224620037,1377,14510.1038/sj.onc.120683414562042Search in Google Scholar
Sakuma, K, Aoki, M, Kannagi, R. ‘Transcription Factors C-Myc and CDX2 Mediate E-Selectin Ligand Expression in Colon Cancer Cells Undergoing EGF/Bfgf-Induced Epithelial-Mesenchymal Transition’, Proc. Natl. Acad. Sci. U.S.A, vol. 109, no. 20, pp., pp. 7,776–7,781.SakumaKAokiMKannagiR‘Transcription Factors C-Myc and CDX2 Mediate E-Selectin Ligand Expression in Colon Cancer Cells Undergoing EGF/Bfgf-Induced Epithelial-Mesenchymal Transition’Proc. Natl. Acad. Sci. U.S.A109207,7767,78110.1073/pnas.1111135109335667822547830Search in Google Scholar
Almaraz, RT, Tian, Y, Bhattarcharya, R, et al. ‘Metabolic Flux Increases Glycoprotein Sialylation: Implications for Cell Adhesion and Cancer Metastasis’, Mol. Cell. Proteomics, vol. 11, no. 7, 2012, M112.017558.AlmarazRTTianYBhattarcharyaR‘Metabolic Flux Increases Glycoprotein Sialylation: Implications for Cell Adhesion and Cancer Metastasis’Mol. Cell. Proteomics1172012M112.017558.10.1074/mcp.M112.017558339495922457533Search in Google Scholar
Miyagi, T, Takahashi, K, Hata, K, Shiozaki, K, Yamaguchi, K. ‘Sialidase Significance for Cancer Progression’, Glycoconj. J, vol. 29, 2012, pp. 567–577.MiyagiTTakahashiKHataKShiozakiKYamaguchiK‘Sialidase Significance for Cancer Progression’Glycoconj. J29201256757710.1007/s10719-012-9394-122644327Search in Google Scholar
Büll, C, den Brok, MH, Adema, GJ. ‘Sweet Escape: Sialic Acids in Tumor Immune Evasion’, Biochim. Biophys. Acta, vol 1,846, no. 1, 2014, pp. 238–246.BüllCden BrokMHAdemaGJ‘Sweet Escape: Sialic Acids in Tumor Immune Evasion’Biochim. Biophys. Acta1,8461201423824610.1016/j.bbcan.2014.07.00525026312Search in Google Scholar
Varki, A, Gagneux, P. ‘Multifarious Roles of Sialic Acids in Immunity’,. Ann. N. Y. Acad. Sci, vol. 1253, no. 1., 2012 pp. 16–36.VarkiAGagneuxP‘Multifarious Roles of Sialic Acids in Immunity’Ann. N. Y. Acad. Sci125312012163610.1111/j.1749-6632.2012.06517.x335731622524423Search in Google Scholar
Ferreira, VP, Pangburn, MK, Cortés, C. ‘Complement Control Protein Factor H: The Good, the Bad, and the Inadequate’ Molecular Immunology, vol. 47, no. 13, pp. 2,187–2,197.FerreiraVPPangburnMKCortésC‘Complement Control Protein Factor H: The Good, the Bad, and the Inadequate’Molecular Immunology47132,1872,19710.1016/j.molimm.2010.05.007292195720580090Search in Google Scholar
Gancz, D, Fishelson, Z. ‘Cancer Resistance to Complement-Dependent Cytotoxicity (CDC): Problem-Oriented Research and Development’, Molecular Immunology, vol. 46, no. 14, 2009, pp. 2,794–2,800.GanczDFishelsonZ‘Cancer Resistance to Complement-Dependent Cytotoxicity (CDC): Problem-Oriented Research and Development’Molecular Immunology461420092,7942,80010.1016/j.molimm.2009.05.00919501402Search in Google Scholar
Pio, R, Ajona, D, Lambris, JD. ‘Complement Inhibition in Cancer Therapy’, Seminars in Immunology, vol. 25, no. 1, pp. 54–64.PioRAjonaDLambrisJD‘Complement Inhibition in Cancer Therapy’Seminars in Immunology251546410.1016/j.smim.2013.04.001373308523706991Search in Google Scholar
Cheng, M, Chen, Y, Xiao, W, Sun, R, Tian, Z. ‘NK Cell-Based Immunotherapy for Malignant Diseases, Cellular and Molecular Immunology, vol. 10,, no. 3, 2013pp. 230–252.ChengMChenYXiaoWSunRTianZ‘NK Cell-Based Immunotherapy for Malignant DiseasesCellular and Molecular Immunology103201323025210.1038/cmi.2013.10407673823604045Search in Google Scholar
Cohen, M. et al., ‘’Sialylation of 3-Methylcholanthrene–Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting’, J. Immunol, vol. 185, no. 10, 2010, pp. 5,869–5,878.CohenM‘’Sialylation of 3-Methylcholanthrene–Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting’J. Immunol1851020105,8695,87810.4049/jimmunol.100163520956342Search in Google Scholar
Jandus, C. et al. ‘Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance’, J. Clin. Invest, vol. 124, no. 4, 2014, \ pp. 1,810–1,820.JandusC‘Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance’J. Clin. Invest124420141,8101,82010.1172/JCI65899397307324569453Search in Google Scholar
Daly, J, Carlsten, M, O’Dwyer, M. ‘Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer’, Front. Immunol, vol. 10, 2019, p. 1,047.DalyJCarlstenMO’DwyerM‘Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer’Front. Immunol1020191,04710.3389/fimmu.2019.01047652179731143186Search in Google Scholar
Park, JE. et al. ‘Fine Specificity of Natural Killer T Cells Against GD3 Ganglioside and Identification of GM3 As an Inhibitory Natural Killer T-Cell Ligand’, Immunology, vol. 123, no. 1, 2008, pp. 145–155.ParkJE‘Fine Specificity of Natural Killer T Cells Against GD3 Ganglioside and Identification of GM3 As an Inhibitory Natural Killer T-Cell Ligand’Immunology1231200814515510.1111/j.1365-2567.2007.02760.x243327318154620Search in Google Scholar
Wondimu, A, Liu, Y, Ma JS, Radoja S, Ladisch S. ‘Ganglioside Inhibition of CD8 + T Cell Cytotoxicity: Interference with Lytic Granule Trafficking and Exocytosis’, J. Immunol, vol. 189, no. 7, 2012, pp. 3,521–3,527.WondimuALiuYMaJSRadojaSLadischS‘Ganglioside Inhibition of CD8 + T Cell Cytotoxicity: Interference with Lytic Granule Trafficking and Exocytosis’J. Immunol189720123,5213,52710.4049/jimmunol.120125622956583Search in Google Scholar
Li, F, Ding, J. ‘Sialylation Is Involved in Cell Fate Decision During Development, Reprogramming and Cancer Progression’, Protein and Cell, vol. 10, no. 8, 2018, pp 550–565.LiFDingJ‘Sialylation Is Involved in Cell Fate Decision During Development, Reprogramming and Cancer Progression’Protein and Cell108201855056510.1007/s13238-018-0597-5662659530478534Search in Google Scholar
Asano, K. et al. ‘CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens’, Immunity, vol. 34, no. 1, 2011; pp. 85–95.AsanoK‘CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens’Immunity3412011859510.1016/j.immuni.2010.12.01121194983Search in Google Scholar
Jales, A. et al., ‘Ganglioside-Exposed Dendritic Cells Inhibit T-Cell Effector Function by Promoting Regulatory Cell Activity’, Immunology, vol. 132, no. 1, 2011, pp. 134–143.JalesA‘Ganglioside-Exposed Dendritic Cells Inhibit T-Cell Effector Function by Promoting Regulatory Cell Activity’Immunology1321201113414310.1111/j.1365-2567.2010.03348.x301508320875076Search in Google Scholar
Munkley, J, Scott, E., ‘Targeting Aberrant Sialylation to Treat Cancer’, Medicines, vol. 6, no. 4, 2019 p. 102.MunkleyJScottE.‘Targeting Aberrant Sialylation to Treat Cancer’Medicines64201910210.3390/medicines6040102696394331614918Search in Google Scholar
Shen, L. et al., ‘Enhanced Expression of α2,3-Linked Sialic Acids Promotes Gastric Cancer Cell Metastasis and Correlates with Poor Prognosis’, Int. J. Oncol, vol. 50, no. 4, 2017 pp. 1,201–1,210.ShenL‘Enhanced Expression of α2,3-Linked Sialic Acids Promotes Gastric Cancer Cell Metastasis and Correlates with Poor Prognosis’Int. J. Oncol50420171,2011,21010.3892/ijo.2017.388228259967Search in Google Scholar
Van Slambrouck, S. et al., ‘Carbohydrate-to-Carbohydrate Interactions Between α2,3-Linked Sialic Acids on α2 Integrin Subunits and Asialo-GM1 Underlie the Bone Metastatic Behaviour of LNCAP-Derivative C4-2B Prostate Cancer Cells’, Biosci. Rep, vol. 34, no. 5, 2014 pp. 546–557.Van SlambrouckS‘Carbohydrate-to-Carbohydrate Interactions Between α2,3-Linked Sialic Acids on α2 Integrin Subunits and Asialo-GM1 Underlie the Bone Metastatic Behaviour of LNCAP-Derivative C4-2B Prostate Cancer Cells’Biosci. Rep345201454655710.1042/BSR20140096416612025137483Search in Google Scholar
Yuan, Q. et al., ‘Modification of α2,6-Sialylation Mediates the Invasiveness and Tumorigenicity of Non-Small Cell Lung Cancer Cells In Vitro and In Vivo Via Notch1/Hes1/MMPs Pathway’, Int. J. Cancer, vol. 143, no. 9, 2018, pp. 1–27.YuanQ‘Modification of α2,6-Sialylation Mediates the Invasiveness and Tumorigenicity of Non-Small Cell Lung Cancer Cells In Vitro and In Vivo Via Notch1/Hes1/MMPs Pathway’Int. J. Cancer1439201812710.1002/ijc.3173729981167Search in Google Scholar
Lu J., et al., ‘β-Galactoside α2,6-Sialyltranferase 1 Promotes Transforming Growth Factor-β-Mediated Epithelial-Mesenchymal Transition’, J. Biol. Chem, vol. 289, no. 50, 2014, pp. 34,627–34,641.LuJ.‘β-Galactoside α2,6-Sialyltranferase 1 Promotes Transforming Growth Factor-β-Mediated Epithelial-Mesenchymal Transition’J. Biol. Chem28950201434,62734,64110.1074/jbc.M114.593392426386925344606Search in Google Scholar
Zhou, X. et al., ‘Sialidase NEU1 Suppresses Progression of Human Bladder Cancer Cells by Inhibiting Fibronectin-Integrin α5β1 Interaction and Akt Signaling Pathway’, Cell Commun. Signal, vol. 18, no. 1, 2020, p. 44.ZhouX‘Sialidase NEU1 Suppresses Progression of Human Bladder Cancer Cells by Inhibiting Fibronectin-Integrin α5β1 Interaction and Akt Signaling Pathway’Cell Commun. Signal18120204410.1186/s12964-019-0500-x706684732164705Search in Google Scholar
Yamanami, H. et al., ‘Down-Regulation of Sialidase NEU4 May Contribute to Invasive Properties of Human Colon Cancers’, Cancer Sci, vol. 98, no. 3, 2007, pp. 299–307.YamanamiH‘Down-Regulation of Sialidase NEU4 May Contribute to Invasive Properties of Human Colon Cancers’Cancer Sci983200729930710.1111/j.1349-7006.2007.00403.x17270019Search in Google Scholar
Roncati, L, Barbolini, G, Gatti, AM, Pusiol, T, Piscioli, F, Maiorana, A., ‘The Uncontrolled Sialylation Is Related to Chemoresistant Metastatic Breast Cancer’, Pathol. Oncol. Res., vol. 22, no. 4, 2016, pp. 869–873.RoncatiLBarboliniGGattiAMPusiolTPiscioliFMaioranaA‘The Uncontrolled Sialylation Is Related to Chemoresistant Metastatic Breast Cancer’Pathol. Oncol. Res224201686987310.1007/s12253-016-0057-627037559Search in Google Scholar
Yen HY. et al. ‘Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition’ Proc. Natl. Acad. Sci. U. S. A., vol. 112, no. 22, 2015, pp. 6,955–6,960.YenHY‘Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition’Proc. Natl. Acad. Sci. U. S. A.1122220156,9556,96010.1073/pnas.1507329112446051325971727Search in Google Scholar
Li, Y, Luo, S, Dong, W, Song, X, Zhou, H, Zhao, L, Jia, L, ‘Alpha-2, 3-Sialyltransferases Regulate the Multidrug Resistance of Chronic Myeloid Leukemia Through miR-4701-5p Targeting ST3GAL1’, Lab. Investig, vol. 96, no. 7, 2016, pp. 731–740.LiYLuoSDongWSongXZhouHZhaoLJiaL‘Alpha-2, 3-Sialyltransferases Regulate the Multidrug Resistance of Chronic Myeloid Leukemia Through miR-4701-5p Targeting ST3GAL1’Lab. Investig967201673174010.1038/labinvest.2016.5027088512Search in Google Scholar
Britain, CM, Holdbrooks, AT, Anderson, JC, Willey, C.D., and Bellis, S.L., ‘Sialylation of EGFR by the ST6Gal-I Sialyltransferase Promotes EGFR Activation and Resistance to Gefitinib-Mediated Cell Death’, J. Ovarian Res, vol. 11, no. 12, p.12.BritainCMHoldbrooksATAndersonJCWilleyC.D.BellisS.L.‘Sialylation of EGFR by the ST6Gal-I Sialyltransferase Promotes EGFR Activation and Resistance to Gefitinib-Mediated Cell Death’J. Ovarian Res11121210.1186/s13048-018-0385-0580001029402301Search in Google Scholar
Büll, C. et al., ‘Targeting Aberrant Sialylation in Cancer Cells Using a Fluorinated Sialic Acid Analog Impairs Adhesion, Migration, and In Vivo Tumor Growth’, Mol. Cancer Ther, vol. 12, no. 10, 2013, pp.1,935–1,946.BüllC‘Targeting Aberrant Sialylation in Cancer Cells Using a Fluorinated Sialic Acid Analog Impairs Adhesion, Migration, and In Vivo Tumor Growth’Mol. Cancer Ther121020131,9351,94610.1158/1535-7163.MCT-13-027923974695Search in Google Scholar
Sharma, P, Allison, JP, ‘Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential’, Cell, vol. 161, no. 2, 2015, pp. 205–214.SharmaPAllisonJP‘Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential’Cell1612201520521410.1016/j.cell.2015.03.030590567425860605Search in Google Scholar
King, T, Posey, AD, ‘Co-Expression of an Engineered Cell-Surface Sialidase by CART Cells Improves Anti-Cancer Activity of NK Cells in Solid Tumors’, Cytotherapy, vol. 21, no. 5, 2019, p. S27.KingTPoseyAD‘Co-Expression of an Engineered Cell-Surface Sialidase by CART Cells Improves Anti-Cancer Activity of NK Cells in Solid Tumors’Cytotherapy2152019S2710.1016/j.jcyt.2019.03.338Search in Google Scholar
Dusoswa, SA. et al., ‘Glycan Modification of Glioblastoma-Derived Extracellular Vesicles Enhances Receptor-Mediated Targeting of Dendritic Cells’, J. Extracell. Vesicles, vol. 8, no. 1, 2019, p. 1,648,995.DusoswaSA‘Glycan Modification of Glioblastoma-Derived Extracellular Vesicles Enhances Receptor-Mediated Targeting of Dendritic Cells’J. Extracell. Vesicles8120191,648,99510.1080/20013078.2019.1648995671314931489145Search in Google Scholar
Wang J., et al., ‘Siglec-15 as an Immune Suppressor and Potential Target for Normalization Cancer Immunotherapy’, Nat. Med, vol. 25, no. 4, 2019, pp. 656–666.WangJ.‘Siglec-15 as an Immune Suppressor and Potential Target for Normalization Cancer Immunotherapy’Nat. Med254201965666610.1038/s41591-019-0374-x717592030833750Search in Google Scholar